Quick Notes: 7 Open Positions

September 3, 2010 10:50 PM ET

 Expect This BioPlastics Maker to Climb Substantially Higher

(>100%) in 2010

• Charts say stock could run in very near future.
• While trading at current levels, it's a must own right now.
• It's NOT Cereplast (CERP)

September 1, 2010 2:25 PM ET

 A Basic Materials Buy

August 31, 2010 6:36 PM ET

 Sell This Cancer Drug Maker

August 30, 2010 8:00 AM ET

 Correction

August 30, 2010 3:40 AM ET

  State of the US Economy

August 28, 2010 2:30 AM ET

 Recommended BioPlastics Maker Advances 17.35%, Take Profits

• Update August 27, 2010 2:00 AM ET

August 26, 2010 8:55 PM ET

 Analysis of iShares NASDAQ Biotech ETF

August 26, 2010 8:10 AM ET

 Sell Prices for RXI's Open Positions

August 26, 2010 5:45 AM ET

 Recommended BioPlastics Maker Obtains EU Contract

August 25, 2010 11:25 PM ET

 Time to Sell This Commodity ===> Gold

August 25, 2010 4:25 AM ET

 Pending Catalysts

• 41 Optionable Drug, Device & Diagnostic Makers Covered

August 23, 2010 8:28 AM ET

 5 Safe Bets in Tough Market

• Updated August 23, 2010 4:00 AM ET

August 19, 2010 5:30 PM ET

 Positive News Before the Bell

August 17, 2010 9:28 AM ET

 Positive Development from Recommended BioPlastics Maker

August 17, 2010 8:00 AM

 Buffett Buys RXI Recommended Nalco

August 16, 2010 5:00 PM ET

 Friday 13 Update

August 13, 2010 10:23 AM ET

 Buy Gold

August 12, 2010 12:00 AM ET

 2 Sell Recommendations

• Updated on August 12, 2010 at 6:00 AM ET

August 11, 2010 10:18 PM ET

 29 Notable Q2 2010 Reports

• Updated on August 7, 2010 at 5:30 AM ET

August 5, 2010 5:40 PM ET

 Sell This Cancer Drug Maker

August 6, 2010 3:10 PM ET

 Notable Q2 2010 Results, Part II

August 6, 2010 7:35 AM ET

 Sell This Drug Maker Price Target Achieved

August 5, 2010 12:30 PM ET

 Fuel Systems Reports +Q2 Results, Surpasses $32 Target

• Update at 4:00 PM ET: +$5.28 (+17.87%)

August 5, 2010 8:12 AM ET

 Positive Q2 Results Reported by RXI Recommended

Cancer Diagnostics Maker

• Shares of the company closed up modestly today.

August 5, 2010 7:25 AM ET

 A Profitable Sell Recommendation

• Update 2:00 PM ET: Only 1 Sell Recommendation Today.

August 3, 2010 1:30 PM ET

 Take Profits in This Cancer Diagnostics Maker

July 29, 2010 4:30 PM ET

 US Optionable Healthcare Index

• Revised & Updated on July 29, 2010 at 3:45 PM ET

July 25, 2010 2:00 PM ET

 RXI's Top 13 Upcoming Regulatory Reviews 

• Revised & Updated on July 29, 2010 at 8:30 AM ET

July 22, 2010 1:05 AM ET

 Three Fantastic Cancer Drug Makers

Potential Catalysts: Pending Clinical Data & Regulatory Reviews during the Second Half of 2010

• Updated July 29, 2010 at 8:00 AM ET
• Updated August 1, 2010 at 3:15 AM ET

July 29, 2010 7:00 AM ET

 Recommendation Jumps 14%+ on Q2 Results

July 29, 2010 6:53 AM ET

 Unloved Biotech Appears Ready for Advance

** Avoid These 19 Healthcare Stocks ** 

July 24, 2010 12:00 PM ET

 Cypress Biosciences Revisited

• July 1 Recommendation Up More Than 140% in 18 Days

July 19, 2010 8:20 PM ET

 Strong Buy Recommendation Reiterated

July 12, 2010 9:28 AM ET

 This BioPlastics Maker Is a Buy

July 8, 2010 10:45 AM ET

 How-To Play Higher Oil Prices

• Updated on July 8, 2010 at 12:42 PM ET

July 8, 2010 9:45 AM ET

 US Short Oil Poised for Double Top

• Conversely, US Oil Forming a Double Bottom
• A Note on Seasonality and July 
• Some Quick Thoughts on Dendreon

July 6, 2010 6:17 PM ET

 A Must Own Medical Device Maker

A hidden gem with very little coverage.

• Innovative solution for a life-threatening disease
• Growth expected from 2010-2012 (company profitable last year)
• Technically positioned to advance in tough market

July 5, 2010 1:00 PM ET

 Reiterating Options Strategy for Unloved Cancer Drug Maker

July 1, 2010 8:38 PM ET

 Play This Specialty Drug Maker with Options

July 1, 2010 2:47 PM ET

 Cancer Drug Maker with 3 Pending Catalysts in 2010 

June 26, 2010 4:00 AM ET

 Specialty Drug Maker with 2 Significant Catalysts in 2010

June 26, 2010 1:00 AM ET

 Options Strategy for Beaten Up Drug Maker

June 22, 2010 4:09 AM ET

 May 24 Buy Recommendation +27%, Take Profits

June 19, 2010 5:40 AM ET

 10 Buys Reiterated

June 18, 2010 10:57 PM ET

 16 Sell Recommendations

• 68.75% (11/16) Profitable
• Recommendations-Closed Positions: 78.6% (22/28) Profitable

June 18, 2010 4:00 AM ET

 Options Strategies for Unloved Cancer Drug Maker

June 10, 2010 10:00 AM ET

 A Game Plan for the Back Half of 2010

June 7, 2010 5:00 AM ET

Modified June 8, 2010 1:30 AM ET

 One Commodity You Must Own

June 2, 2010 3:06 PM ET

 Al & Tipper Have Seperated 

But Here's Some Info You Might Actually Care to Know

June 1, 2010 1:52 PM ET

 Lower We Go

May 25, 2010 7:40 AM ET

 Specialty Drug Maker With Promising Treatment for Elderly

May 24, 2010 6:24 AM ET

 Clean Energy Play Has BIG Gain Potential

May 21, 2010 6:00 AM ET

• This is a great find! 
• Potential Gain: 100% to 400%

 Going Forward

May 20, 2010 1:24 AM ET

PLEASE POST COMMENTS 

 Buy Alert: Underappreciated Specialty Drug Maker

May 19, 2010 12:00 AM ET

 $2 Cancer Play Advances on Q1 '10 Report

• Updated on May 14, 2010 at 11:35 and 1:40 PM ET

May 14, 2010 10:35 AM ET

  FDA Panel Rules in Favor of Questcor’s Acthar Gel 

 This Biotech Research Firm Is a Buy

May 5, 2010

  Ariad Pharma Going Forward

May 5, 2010

Updated: May 6, 2010 11:25 AM ET

 Advancing Clean Energy Stocks

May 4, 2010 8:00 AM ET

 Unknown, Promising Cancer Drug Maker Sub-$2

 An Oil Spill Play

 April 29 Buy Pozen (POZN) Obtains Approval, Hits New High

May 3, 2010 7:53 AM ET

 $2 Buy Alert

May 3, 2010 7:34 AM ET

 Two Drug Makers with Pending FDA Decisions

April 29, 2010 11:53 AM ET

 A Play on Shock Absorption

 Dendreon Overvalued, But This Drug Maker Should Advance

April 27, 2010

 So, What's Next?

April 26, 2010